Compare CVLG & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVLG | PHAR |
|---|---|---|
| Founded | 1986 | 1988 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 867.7M | 793.4M |
| IPO Year | 1996 | 2020 |
| Metric | CVLG | PHAR |
|---|---|---|
| Price | $33.88 | $10.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $38.33 |
| AVG Volume (30 Days) | ★ 217.9K | 16.8K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $705,007,000.00 | N/A |
| Revenue This Year | $7.17 | $10.04 |
| Revenue Next Year | $7.53 | $2.51 |
| P/E Ratio | ★ $69.10 | $3,041.22 |
| Revenue Growth | ★ 5.12 | N/A |
| 52 Week Low | $18.00 | $9.62 |
| 52 Week High | $49.88 | $21.34 |
| Indicator | CVLG | PHAR |
|---|---|---|
| Relative Strength Index (RSI) | 36.03 | 41.81 |
| Support Level | $33.06 | $9.62 |
| Resistance Level | $35.90 | $13.51 |
| Average True Range (ATR) | 1.36 | 0.42 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 15.14 | 20.77 |
Covenant Logistics Group Inc together with its wholly-owned subsidiaries, offers truckload transportation and freight brokerage services to customers throughout the continental United States. The company's reportable segments include Expedited, Dedicated Services, Managed Freight, and Warehousing. The expedited segment provides truckload services to customers with high service freight and delivery standards. Dedicated segment provides customers with committed truckload capacity over contracted periods with the goal of three to five years in length. The Managed Freight segment includes brokerage services and TMS. The warehousing segment provides day-to-day warehouse management services to customers who have chosen to outsource this function.
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.